Search research articles
Contact Us
Filters
Showing results (251-260 of 329) with videos related to
Page
of 33
Sort By:
Open Forum Infectious Diseases
|
May 25, 2019
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
Sidonie Lambert-Niclot, Anders Boyd, Djeneba Fofana, et al.
The Lancet. HIV
|
July 29, 2022
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study
Birgit Schramm, Elvis Temfack, Diane Descamps, et al.
Scandinavian Journal of Infectious Diseases
|
March 13, 2010
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients
Fabienne Caby, Nadia Valin, Anne Genevieve Marcelin, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
October 22, 2024
Dynamics of SARS-CoV-2 variants in West Africa: Insights into genomic surveillance in resource-constrained settings
Josue Togo, Anou Moise Somboro, Oumar Dolo, et al.
The Journal of Antimicrobial Chemotherapy
|
April 30, 2021
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir
Basma Abdi, Sidonie Lambert-Niclot, Marc Wirden, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2025
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable
Cathia Soulie, Rachid Agher, Antoine Fauchois, et al.
Journal of Global Antimicrobial Resistance
|
August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study
Maria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.
The Journal of Antimicrobial Chemotherapy
|
January 9, 2025
Major role of dolutegravir in the emergence of the S147G integrase resistance mutation
Marc Wirden, Basma Abdi, Sidonie Lambert-Niclot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2012
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy
Benjamin Ribba, Gentian Kaloshi, Mathieu Peyre, et al.
The Journal of Infectious Diseases
|
April 14, 2020
New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies
Aude Jary, Valentin Leducq, Nathalie Desire, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 329) with videos related to
Sort By:
Page
of 33
Open Forum Infectious Diseases
|
May 25, 2019
INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels
Sidonie Lambert-Niclot, Anders Boyd, Djeneba Fofana, et al.
The Lancet. HIV
|
July 29, 2022
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study
Birgit Schramm, Elvis Temfack, Diane Descamps, et al.
Scandinavian Journal of Infectious Diseases
|
March 13, 2010
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients
Fabienne Caby, Nadia Valin, Anne Genevieve Marcelin, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
October 22, 2024
Dynamics of SARS-CoV-2 variants in West Africa: Insights into genomic surveillance in resource-constrained settings
Josue Togo, Anou Moise Somboro, Oumar Dolo, et al.
The Journal of Antimicrobial Chemotherapy
|
April 30, 2021
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir
Basma Abdi, Sidonie Lambert-Niclot, Marc Wirden, et al.
The Journal of Antimicrobial Chemotherapy
|
December 16, 2025
Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable
Cathia Soulie, Rachid Agher, Antoine Fauchois, et al.
Journal of Global Antimicrobial Resistance
|
August 10, 2022
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study
Maria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, et al.
The Journal of Antimicrobial Chemotherapy
|
January 9, 2025
Major role of dolutegravir in the emergence of the S147G integrase resistance mutation
Marc Wirden, Basma Abdi, Sidonie Lambert-Niclot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2012
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy
Benjamin Ribba, Gentian Kaloshi, Mathieu Peyre, et al.
The Journal of Infectious Diseases
|
April 14, 2020
New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies
Aude Jary, Valentin Leducq, Nathalie Desire, et al.
Page
of 33